CD86 and infection: IDO is upmodulated during antigen presentation by the engagement of CTLA-4/B7.1/B7.2 (CD80/CD86) molecules on lymphocytes and human dendritic cells (DCs), in response to infection and tissue inflammation (TNF-α, PGE2, IFN-α/β/γ secretion) [2–4].